Basic Information
Basic information for SOX9-AS1-222-41aa
Peptide Name SOX9-AS1-222-41aa
Genome Position chr17:72071044-72071044,72081360-72081401,72081962-72082041[-]
Species Human
Peptide Sequence MGFHVLWLLVEFTQWRTLARGRKRGGRLYDTCVECAGSLHR
Peptide Length 41
Unique No (SOX9-AS1-212-41aa,SOX9-AS1-235-41aa)
Grand Average of Hydropathicity -0.1902
Relative Molecular Mass 5541.33
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000234899;SOX9-AS1
Transcript ID/Name ENST00000655414;SOX9-AS1-222
Transcript Length 714
Coding Ability 0.437
DNA Sequence Corresponding to Peptide ATGGGTTTCCATGTCCTTTGGCTTCTGGTTGAGTTCACTCAGTGGAGAACCCTGGCAAGAGGCAGGAAAAGGGGAGGAAGGCTTTATGATACATGTGTTGAATGTGCAGGTTCGTTACATAGG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :